Utilizing sophisticated bioinformatics tools, we analyze large datasets to identify and validate genetic biomarkers associated with disease susceptibility, prognosis, and treatment response, supporting patient stratification and precision medicine strategies.

Our capabilities extend to conducting longitudinal genomic studies, crucial for understanding disease progression, treatment resistance mechanisms, and the long-term efficacy and safety of therapeutics.​